Back to results
US 2025/0367125 A1Published application
Oral polypeptide composition
AssigneeShenzhen Oralead Pharma Co., LTD.
InventorsBanghao YUAN, Yusheng Sui, Liu Dou
Life of this patent
Estimating the term…
Abstract
An oral polypeptide composition for improving the gastrointestinal absorption of polypeptide drugs is provided. The oral polypeptide composition includes polypeptide molecules, medium-chain fatty acids (MCFA) and their salts, amino acids and N-(8-(2-hydroxybenzoyl) amino) caprylic acid (NAC) and its salts. The oral polypeptide composition can effectively increase the plasma drug concentration of the polypeptide and improve the oral bioavailability of the polypeptide.
Claims20
An oral polypeptide composition, wherein the oral polypeptide composition comprises:
- a polypeptide targeting the GLP-1 receptor, one or more amino acids present as individual components, N-(8-[2-hydroxybenzoyl]-amino) caprylic acid (NAC) or a salt thereof, and medium-chain fatty acids or a salt thereof;
- a total content of the one or more amino acids, the NAC or salt thereof, and the medium-chain fatty acid or a salt thereof in the oral polypeptide composition is 50-90% w/w.
Dependencies are inferred from the claim text.